Publications by authors named "Andrea Peter"

Claim this Profile
G
Genetic Analysis of Patients with Chronic Thromboembolic Pulmonary Hypertension (CTEPH): A Single-Center Observational Study.
Zsuzsanna Bereczky, Gábor Kolodzey, Sarolta Borsos, László Balogh, Petra Erzsébet Biró

Genes (Basel)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Chronic thromboembolic pulmonary hypertension - the hidden disease].
Gábor Kolodzey, László Balogh, Judit Barta, Andrea Péter, Tibor Szűk

Orv Hetil· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Right Ventricular Pressure in Chronic Thromboembolic Pulmonary Hypertension: Comparison of Diagnostic Modalities and Balloon Pulmonary Angioplasty Outcomes.
Gábor Kolodzey, Andrea Péter, Andrea Daragó, László Balogh, Zsuzsanna Bereczky

Diagnostics (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
18F-FDG PET/CT Impact on Malignant Melanoma Patients Undergoing Staging and Restaging: A Single-University-Center Experience in a Real-World Setting.
Silvija Lucic, Milena Spirovski, Borislava Nikolin, Dragana Stojanovic, Andrea Peter

Diagnostics (Basel)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
18F-FDG PET/CT- and MRI-Based Locally Advanced Cervical Cancer Early-Response Assessment after Concurrent Chemo- and Radiotherapy-Impact on Patient Outcomes and Survival Prediction.
Silvija Lucic, Milena Spirovski, Dragana Stojanovic, Andrea Peter, Jelena Licina

Diagnostics (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triple Therapy with Mometasone/Indacaterol/Glycopyrronium or Doubling the ICS/LABA Dose in GINA Step 4: IRIDIUM Analyses.
Richard N van Zyl-Smit, Huib A M Kerstjens, Jorge Maspero, Ana-Maria Tanase, David Lawrence, Peter D'Andrea

Pulm Ther· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, Safety, and Systemic Exposure of Once-Daily Indacaterol Acetate in Pediatric Asthma: A Randomized, Double-Blind, Controlled Dose-Finding Study.
Bulent Enis Sekerel, Haylene Nell, Istvan Laki, Tatiana Pak, Edgar Contreras, Peter D'Andrea

Clin Drug Investig· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of once-daily, single-inhaler, fixed-dose combination of mometasone/indacaterol/glycopyrronium in patients with asthma with or without persistent airflow limitation: Post hoc analysis from the IRIDIUM study.
Richard N Van Zyl-Smit, Huib Am Kerstjens, Jorge F Maspero, Konstantinos Kostikas, Motoi Hosoe, Peter D'Andrea

Respir Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety of once-daily indacaterol acetate/glycopyrronium bromide/mometasone furoate high-dose, and indacaterol acetate/mometasone furoate high-dose, in Japanese patients with inadequately controlled asthma: Results from two open-label, 52-week studies.
Hironori Sagara, Peter D'Andrea, Ana-Maria Tanase, Abhijit Pethe, Yukina Tanaka

J Asthma· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mometasone/Indacaterol/Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus Fluticasone Propionate/Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ Tiotropium in Patients with Asthma.
Richard N van Zyl-Smit, Kenneth R Chapman, Huib A M Kerstjens, Christian Gessner, Hironori Sagara, Peter D'Andrea

J Asthma Allergy· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subclinical systolic and diastolic myocardial dysfunction in polyphasic polymyositis/dermatomyositis: a 2-year longitudinal study.
Andrea Péter, Ágnes Balogh, Zoltán Csanádi, Katalin Dankó, Zoltan Griger

Arthritis Res Ther· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Review of the Unique Drug Development Strategy of Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate: A First-in-Class, Once-Daily, Single-Inhaler, Fixed-Dose Combination Treatment for Asthma.
Dominic Brittain, Peter D'Andrea, Emilie Gruen, Motoi Hosoe, Devendra Jain

Adv Ther· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular safety of mometasone/indacaterol and mometasone/indacaterol/glycopyrronium once-daily fixed-dose combinations in asthma: pooled analysis of phase 3 trials.
Emil Scosyrev, Richard van Zyl-Smit, Huib Kerstjens, Christian Gessner, Oliver Kornmann, Peter D'Andrea

Respir Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of 3D echocardiography-determined atrial volumes in distinguishing between pre-capillary and post-capillary pulmonary hypertension.
Csaba Jenei, Rebeka Kádár, László Balogh, Attila Borbély, Ferenc Győry

ESC Heart Fail· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One time a day mometasone/indacaterol fixed-dose combination versus two times a day fluticasone/salmeterol in patients with inadequately controlled asthma: pooled analysis from PALLADIUM and IRIDIUM studies.
Kenneth Chapman, Richard van Zyl-Smit, Jorge Maspero, Huib A M Kerstjens, Yasuhiro Gon, Peter D'Andrea

BMJ Open Respir Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-daily, single-inhaler mometasone-indacaterol-glycopyrronium versus mometasone-indacaterol or twice-daily fluticasone-salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study.
Huib A M Kerstjens, Jorge Maspero, Kenneth R Chapman, Richard N van Zyl-Smit, Motoi Hosoe, Peter D'Andrea

Lancet Respir Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-daily mometasone plus indacaterol versus mometasone or twice-daily fluticasone plus salmeterol in patients with inadequately controlled asthma (PALLADIUM): a randomised, double-blind, triple-dummy, controlled phase 3 study.
Richard N van Zyl-Smit, Matthias Krüll, Christian Gessner, Yasuhiro Gon, Oliver Noga, Peter D'Andrea

Lancet Respir Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of inhaled once-daily low-dose indacaterol acetate/mometasone furoate in patients with inadequately controlled asthma: Phase III randomised QUARTZ study findings.
Oliver Kornmann, Janos Mucsi, Nadezda Kolosa, Lorraine Bandelli, Biswajit Sen, Peter D'Andrea

Respir Med· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlations between FEV1 and patient-reported outcomes: A pooled analysis of 23 clinical trials in patients with chronic obstructive pulmonary disease.
James F Donohue, Paul W Jones, Christian Bartels, Jessica Marvel, Peter D'Andrea

Pulm Pharmacol Ther· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study.
Craig LaForce, Gregory Feldman, Selwyn Spangenthal, Joerg H Eckert, Michelle Henley, Peter D'Andrea

Int J Chron Obstruct Pulmon Dis· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Localization and pneumococcal alteration of junction proteins in the human alveolar-capillary compartment.
Andrea Peter, Diana Fatykhova, Olivia Kershaw, Achim D Gruber, Jens Rueckert

Histochem Cell Biol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety of glycopyrrolate: A randomized study in patients with moderate-to-severe COPD (GEM3).
Donald A Mahler, Alex H Gifford, Aditi Satti, Nicola Jessop, Joerg H Eckert, Peter D'Andrea

Respir Med· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of inhaled glycopyrronium in patients with COPD: a comprehensive analysis of clinical studies and post-marketing data.
Anthony D D'Urzo, Edward M Kerwin, Kenneth R Chapman, Marc Decramer, Robert DiGiovanni, Peter D'Andrea

Int J Chron Obstruct Pulmon Dis· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Twice-Daily Glycopyrrolate Versus Placebo in Patients With COPD: The GEM2 Study.
Edward Kerwin, Thomas M Siler, Phillip Korenblat, Alexander White, Joerg H Eckert, Peter D'Andrea

Chronic Obstr Pulm Dis· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IFNs Modify the Proteome of Legionella-Containing Vacuoles and Restrict Infection Via IRG1-Derived Itaconic Acid.
Jan Naujoks, Christoph Tabeling, Brian D Dill, Christine Hoffmann, Andrew S Brown, Andrea Peter

PLoS Pathog· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis